rs708686

GWAS Catalog Trait Associations (44)

Genome-wide significant associations (p < 5×10⁻⁸) from the NHGRI-EBI GWAS Catalog.

protein measurement

Pietzner M et al. Mapping the proteo-genomic convergence of human diseases. Science (new York, N.y.) 374(6569):eabj1541 (2021)
Allele T
OR 0.78
p
N 10,708
Large GWAS
European

protein FAM3B measurement

Allele T
OR 0.22
p 2.0e-306
N 47,745
Large GWAS
European

galactoside 3(4)-L-fucosyltransferase measurement

Sun BB et al. Genomic atlas of the human plasma proteome. Nature 558(7708):73-79 (2018)
Allele T
OR
β 0.850
p 3.0e-273
N 3,301
Large GWAS
European
Allele T
OR 0.78
p 2.0e-171
N 2,935
Large GWAS
Greater Middle Eastern (Middle Eastern, North African or Persian)

blood protein amount

Allele T
OR 0.68
p 1.0e-258
N 5,361
Large GWAS
European
Emilsson V et al. Co-regulatory networks of human serum proteins link genetics to disease. Science (new York, N.y.) 361(6404):769-773 (2018)
Allele T
OR 0.66
p 3.0e-126
N 3,200
Large GWAS
European

cancer antigen 19.9 measurement

Olafsson S et al. Common and Rare Sequence Variants Influencing Tumor Biomarkers in Blood. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 29(1):225-235 (2020)
Allele T
OR 0.52
p 2.0e-179
N 9,945
Large GWAS
European

level of meprin A subunit alpha in blood

Allele T
OR 0.15
p 5.0e-138
N 47,745
Large GWAS
European

level of cadherin-17 in blood serum

Allele T
OR 0.12
p 9.0e-133
N 47,745
Large GWAS
European

level of Ly6/PLAUR domain-containing protein 8 in blood serum

Allele T
OR 0.15
p 9.0e-130
N 47,745
Large GWAS
European

serine protease 27 measurement

Allele T
OR 0.12
p 4.0e-112
N 47,745
Large GWAS
European

This variant is in our database but has no known associations or PRS memberships yet.

Gene information from NCBI Gene. Variant classifications from ClinVar.

Community Wiki

No community notes yet for this variant. Sign in to start one.

Comments

Sign in to join the discussion.

Loading comments…